Diadem Announces Publication of Clinical Data Showing Its AlzoSure® Biomarker Test Accurately Predicts Progression to Alzheimer's Disease Six Years Before Diagnosis
/PRNewswire/ -- Diadem srl, a company developing the first blood-based test for the early prediction of progression to Alzheimer's disease (AD), today...
Source: prnewswire.com